Alpine Immune Sciences, Inc. (ALPN)

Alpine Immune Sciences Revenue

In the year 2023, Alpine Immune Sciences had annual revenue of $58.88M with 95.84% growth. Revenue in the quarter ending December 31, 2023 was $30.85M with 1,011.42% year-over-year growth.

• Revenue (ttm): $58.88M
• Revenue Growth: +95.84%
• P/S Ratio: 71.95
• Revenue / Employee: $414,620
• Employees: 142
• Market Cap: 4.23B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	58.88M	28.81M	95.84%
Dec 31, 2022	30.06M	6.62M	28.24%
Dec 31, 2021	23.44M	14.11M	151.13%
Dec 31, 2020	9.34M	7.60M	436.49%
Dec 31, 2019	1.74M	1.04M	146.81%
Dec 31, 2018	705.00K	-1.03M	-59.27%
Dec 31, 2017	1.73M	-1.22M	-41.32%
Dec 31, 2016	2.95M	2.46M	499.59%
Dec 31, 2015	492.00K	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.